Hospital
ST Lukes Community Hospital
ST Lukes Community Hospital was paid $699K by Medicaid between Jan 2018 and Dec 2024, across 168 billing codes. Its largest line is 92507, Treatment of speech, language, voice, communication, and/or auditory processing disorder — 13% of everything it billed.
33Billing provider infoST LUKES COMMUNITY HOSPITAL
RONAN, MT 59864
RONAN, MT 59864
33aNPI1336213446assigned 11/20/2006
33bProvider typeMedicare Defined Swing Bed Hospital Unit
28Total paid$699K
24GClaims331,457
24DCodes billed168
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Medicare Defined Swing Bed Hospital Unit providers in Montana
Rank by total paid#2 of 8
Median peer was paid$14K
This provider vs. median48×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 56,805 | $109K | |
| 2019 | 53,167 | $101K | |
| 2020 | 44,676 | $76K | |
| 2021 | 53,843 | $98K | |
| 2022 | 50,722 | $112K | |
| 2023 | 44,178 | $99K | |
| 2024incomplete | 28,066 | $104K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 13% | 9,258 | 2,961 | $93K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 9.8% | 6,033 | 4,433 | $69K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 9.3% | 6,798 | 6,166 | $65K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 7.5% | 1,573 | 1,130 | $52K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 7.1% | 5,429 | 4,072 | $50K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 5.3% | 14,805 | 4,736 | $37K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 5.2% | 4,237 | 3,447 | $37K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 4.0% | 6,230 | 2,457 | $28K |
| G0378 | Hospital observation service, per hour | 2.4% | 2,485 | 1,607 | $17K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 1.9% | 14,846 | 4,559 | $13K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.9% | 3,744 | 2,229 | $13K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.8% | 1,783 | 1,289 | $12K |
156 more codes
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.6% | 2,088 | $11K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.6% | 4,621 | $11K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1.5% | 974 | $11K |
| 80053 | Comprehensive metabolic panel | 1.5% | 18,406 | $11K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.5% | 6,495 | $11K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.3% | 6,044 | $9K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.2% | 7,673 | $9K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.2% | 19,858 | $8K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.0% | 5,454 | $7K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,823 | $7K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 1,706 | $6K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 2,169 | $6K |
| 81001 | <1% | 9,121 | $5K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,268 | $5K |
| J3490 | Unclassified drugs | <1% | 4,540 | $4K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 7,135 | $4K |
| 71045 | Radiologic examination, chest; single view | <1% | 2,584 | $4K |
| 97162 | <1% | 1,301 | $4K | |
| 80050 | General health panel | <1% | 2,199 | $3K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,873 | $3K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 5,737 | $3K |
| 87088 | <1% | 4,144 | $3K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 132 | $3K |
| 36415 | Collection of venous blood by venipuncture | <1% | 17,514 | $3K |
| 83605 | <1% | 5,236 | $3K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 837 | $3K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 2,251 | $3K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 2,233 | $2K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 885 | $2K |
| 86140 | <1% | 5,542 | $2K | |
| 81025 | <1% | 1,680 | $2K | |
| J2704 | Injection, propofol, 10 mg | <1% | 1,592 | $2K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 3,991 | $2K |
| 83690 | <1% | 3,817 | $2K | |
| 96376 | <1% | 1,940 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,439 | $2K |
| 87186 | <1% | 2,277 | $2K | |
| 87040 | <1% | 3,346 | $2K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 4,386 | $2K |
| 97161 | <1% | 349 | $2K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 4,775 | $2K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 451 | $2K |
| 84703 | <1% | 1,288 | $1K | |
| 73630 | <1% | 309 | $1K | |
| 84145 | <1% | 2,811 | $1K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,058 | $1K |
| 82977 | <1% | 787 | $1K | |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 825 | $1K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 873 | $1K |
| 85651 | <1% | 2,376 | $922.38 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 580 | $905.61 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,706 | $856.36 |
| 87420 | <1% | 255 | $783.02 | |
| 74022 | <1% | 188 | $677.06 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 1,059 | $634.33 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,775 | $611.69 |
| 87400 | <1% | 84 | $533.70 | |
| 84478 | <1% | 548 | $516.79 | |
| 83550 | <1% | 609 | $439.34 | |
| 84439 | <1% | 873 | $437.58 | |
| A9270 | Non-covered item or service | <1% | 11,180 | $431.08 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,276 | $418.83 |
| 83540 | <1% | 649 | $412.13 | |
| 80061 | Lipid panel | <1% | 3,547 | $406.75 |
| 73610 | <1% | 246 | $398.33 | |
| 82150 | <1% | 688 | $353.33 | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 67 | $349.57 |
| 73130 | <1% | 141 | $303.70 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,521 | $288.11 |
| 85610 | <1% | 2,624 | $281.16 | |
| 87070 | <1% | 438 | $270.40 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,136 | $256.64 |
| 84480 | <1% | 254 | $234.38 | |
| 82962 | <1% | 2,050 | $233.87 | |
| 90715 | <1% | 19 | $231.49 | |
| 83880 | <1% | 742 | $229.22 | |
| 73030 | <1% | 69 | $228.15 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 30 | $199.43 |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 158 | $196.58 |
| 86141 | <1% | 509 | $190.79 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 849 | $189.53 |
| 92508 | Group treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 351 | $180.18 |
| 97168 | <1% | 12 | $170.88 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 294 | $145.38 |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | <1% | 2,759 | $144.62 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 194 | $134.39 |
| 86803 | <1% | 393 | $119.95 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 120 | $117.18 |
| 85027 | <1% | 234 | $111.89 | |
| 82728 | <1% | 268 | $106.00 | |
| 84484 | <1% | 3,073 | $102.47 | |
| 94760 | <1% | 1,124 | $79.65 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 1,018 | $78.71 |
| 86308 | <1% | 26 | $62.67 | |
| 87081 | <1% | 347 | $55.74 | |
| 73562 | <1% | 106 | $55.26 | |
| 86780 | <1% | 154 | $43.81 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 48 | $41.13 |
| 83735 | <1% | 969 | $39.09 | |
| 86677 | <1% | 12 | $37.40 | |
| 82607 | <1% | 283 | $29.32 | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 4,008 | $27.96 |
| 85730 | <1% | 234 | $23.36 | |
| 97035 | <1% | 97 | $18.09 | |
| 82570 | <1% | 142 | $13.35 | |
| 82550 | 0% | 360 | $0.00 | |
| 99214 | Doctor's office visit, returning patient (more involved) | 0% | 842 | $0.00 |
| 85379 | 0% | 442 | $0.00 | |
| 76830 | Ultrasound, transvaginal | 0% | 12 | $0.00 |
| 82553 | 0% | 203 | $0.00 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 0% | 217 | $0.00 |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 0% | 19 | $0.00 |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 0% | 24 | $0.00 |
| 82043 | 0% | 13 | $0.00 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 0% | 43 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 18 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 21 | $0.00 |
| 80055 | 0% | 61 | $0.00 | |
| 82746 | 0% | 38 | $0.00 | |
| 86901 | 0% | 31 | $0.00 | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 0% | 94 | $0.00 |
| 86850 | 0% | 19 | $0.00 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 0% | 27 | $0.00 |
| 90686 | 0% | 15 | $0.00 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 20 | $0.00 |
| 87077 | 0% | 17 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 13 | $0.00 |
| J3411 | Injection, thiamine hcl, 100 mg | 0% | 21 | $0.00 |
| Q3014 | Telehealth originating site facility fee | 0% | 14 | $0.00 |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 0% | 359 | $0.00 |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 0% | 17 | $0.00 |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 0% | 145 | $0.00 |
| 99203 | Doctor's office visit, new patient (routine) | 0% | 17 | $0.00 |
| 73110 | 0% | 35 | $0.00 | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 0% | 12 | $0.00 |
| 76000 | 0% | 13 | $0.00 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 0% | 21 | $0.00 |
| 81003 | 0% | 122 | $0.00 | |
| 72125 | Computed tomography, cervical spine; without contrast material | 0% | 50 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 120 | $0.00 |
| 86200 | 0% | 14 | $0.00 | |
| 80074 | 0% | 65 | $0.00 | |
| 90662 | 0% | 13 | $0.00 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 0% | 53 | $0.00 |
| 86038 | 0% | 14 | $0.00 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 0% | 61 | $0.00 |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 0% | 12 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 19 | $0.00 |
| 86900 | 0% | 12 | $0.00 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 0% | 25 | $0.00 |
| 96367 | 0% | 19 | $0.00 | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 0% | 12 | $0.00 |
| 72100 | 0% | 19 | $0.00 | |
| 99215 | Doctor's office visit, returning patient (complex) | 0% | 24 | $0.00 |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 0% | 14 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialROBERTS, SHANE (CHIEF EXECUTIVE OFFICER)
| Provider | Location | Paid |
|---|---|---|
| ST Lukes Community Hospital | Ronan, MT | $122K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.